CFG
MRNA icon

Cooper Financial Group’s Moderna MRNA Stock Holding History

Cooper Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,287
Closed -$222K – 272
2022
Q1 		$222K Sell
1,287
-1,126
-47% -$190K 0.08% 222
2021
Q4 		$613K Buy
2,413
+174
+8% +$50.9K 0.23% 102
2021
Q3 		$862K Hold
2,239
– – 0.18% 87
2021
Q2 		$526K Buy
2,239
+39
+2% +$6.97K 0.11% 118
2021
Q1 		$288K Sell
2,200
-906
-29% -$131K 0.07% 190
2020
Q4 		$324K Buy
+3,106
New +$314K 0.07% 208

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cooper Financial Group's MRNA Position: Q2 2022 in Review

Cooper Financial Group sold out of Moderna (MRNA) in Q2 2022, closing a stake of 1,287 shares — an estimated $222K sold.

Cooper Financial Group first reported a position in MRNA in Q4 2020 and held it in 6 quarters. The position peaked at $862K in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Cooper Financial Group reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Cooper Financial Group sold 1,287 Moderna shares in Q2 2022, an estimated $222K.
  • Cooper Financial Group first reported a position in Moderna in Q4 2020 and held it in 6 quarters.
  • Cooper Financial Group's Moderna position peaked at $862K in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Cooper Financial Group's 13F filing for Q2 2022, filed 11 Jul 2022.